Qiagen N.V (QGEN) | Stock Overview & Key Data
Qiagen N.V Performance Comparison
Stock Range
Today's Range
52 Week Range
All-Time High: $60.81 on July 17, 2000
Explore how other US stocks compare to their 52-week ranges: View US Market 52-Week Insights
Key Statistics
Join Our United States Telegram Channel
Get Instant Market Updates: 52-Week High/Low Alerts, Breakout Notifications & Expert Stock Analysis Delivered To Your Phone. Join Traders Making Informed Decisions Daily!
Financial Highlights
Quarter Income Flow
Dec 31, 2025
Annual Income Flow
2025
Peer Performance Comparison
| Company | Market Cap | 1W | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Qiagen N.V
QGEN
|
7.92B Mid-cap | 2.15% | 12.22% | -9.56% | -18.55% | -18.10% | -21.33% | -20.74% | -21.35% | 73.02% | 86.70% | 167.97% |
|
Thermo Fisher
TMO
|
174.55B Large-cap | 0.87% | 8.07% | 0.79% | -17.74% | -20.05% | 16.53% | -12.65% | -2.72% | 220.94% | 654.32% | 1,231.84% |
|
Danaher
DHR
|
126.39B Large-cap | -1.32% | 11.85% | -5.38% | -20.75% | -21.40% | -10.25% | -15.98% | -20.94% | 174.08% | 416.93% | 738.84% |
|
Revvity
RVTY
|
9.74B Mid-cap | 0.25% | 7.00% | 16.27% | 1.48% | 2.45% | 6.55% | -16.43% | -33.86% | 90.37% | 284.64% | 376.61% |
|
Icon plc
ICLR
|
8.98B Mid-cap | -2.97% | 26.93% | 51.34% | -19.88% | -21.70% | 0.36% | -37.56% | -31.10% | 128.30% | 504.05% | 1,004.91% |
|
Charles River
CRL
|
8.28B Mid-cap | 1.09% | 24.94% | 24.02% | -4.89% | -6.89% | 25.47% | -10.71% | -46.99% | 128.42% | 379.20% | 406.37% |
Ownership & Short Interest
Calculate Your Qiagen N.V Investment Returns
Long-Term Investment Performance Analysis
Qiagen N.V stock price in Jul 2016 was $23.98, A $1,000.00 lump sum investment in Qiagen N.V made 9 years ago would be worth approximately $1,543.37 today, representing a solid return of 54.34%. This translates to an annualized return (CAGR) of 4.48%.
9 Years 10 Months Investment Scenario (Jul 2016 - Jun 2026)
Investment Breakdown
Value Comparison
Disclaimer: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing. Past performance does not guarantee future results.
Frequently Asked Questions
- What is QGEN's 52-week high and low?
- In the last 52 weeks, Qiagen N.V reached a high of $57.82 (on N/A) and a low of $32.53 (on N/A).
- What is the market cap and P/E ratio for QGEN?
- Curious about Qiagen N.V's size and valuation? Its market capitalization stands at 7.92B. When it comes to valuation, the P/E ratio (trailing twelve months) is 18.76, and the forward P/E (looking ahead) is 13.90.
- Does QGEN pay dividends? If so, what's the yield?
- As for dividends, Qiagen N.V isn't currently offering a significant yield, or that specific data isn't available right now.
- Who are Qiagen N.V's main competitors or similar companies to consider before investing?
When looking at Qiagen N.V, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
Company Mkt Cap Sector Industry 1Y Return 3Y Return Thermo Fisher
TMO174.55B Healthcare Diagnostics & Research 16.53% -12.65% Danaher
DHR126.39B Healthcare Diagnostics & Research -10.25% -15.98% Revvity
RVTY9.74B Healthcare Diagnostics & Research 6.55% -16.43% Icon plc
ICLR8.98B Healthcare Diagnostics & Research 0.36% -37.56% Charles River
CRL8.28B Healthcare Diagnostics & Research 25.47% -10.71% For a more comprehensive list, please see the Peer Performance Comparison table on this page.
- What are the key financial health indicators for Qiagen N.V.? (e.g., ROE, Debt/Equity)
- To get a sense of Qiagen N.V's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is 11.57%, the Debt to Equity ratio from the most recent quarter is 48.56, and its Gross Profit Margin stands at 60.19%.
- What is the recent revenue and earnings growth for QGEN?
- Looking at Qiagen N.V's growth, its revenue over the trailing twelve months (TTM) was $2B. Compared to the same quarter last year (YoY), quarterly revenue grew by 3.70%, and quarterly earnings saw a YoY growth of 22.10%.
- How much of QGEN stock is held by insiders and institutions?
- Wondering who owns Qiagen N.V stock? Company insiders (like executives and directors) hold about 0.46% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 75.57%.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.